113 related articles for article (PubMed ID: 16235302)
1. Propylthiouracil for alcoholic liver disease.
Rambaldi A; Gluud C
Cochrane Database Syst Rev; 2005 Oct; (4):CD002800. PubMed ID: 16235302
[TBL] [Abstract][Full Text] [Related]
2. Propylthiouracil for alcoholic liver disease.
Fede G; Germani G; Gluud C; Gurusamy KS; Burroughs AK
Cochrane Database Syst Rev; 2011 Jun; 2011(6):CD002800. PubMed ID: 21678335
[TBL] [Abstract][Full Text] [Related]
3. Propylthiouracil for alcoholic liver disease.
Rambaldi A; Gluud C
Cochrane Database Syst Rev; 2002; (2):CD002800. PubMed ID: 12076451
[TBL] [Abstract][Full Text] [Related]
4. Anabolic-androgenic steroids for alcoholic liver disease.
Rambaldi A; Iaquinto G; Gluud C
Cochrane Database Syst Rev; 2003; (1):CD003045. PubMed ID: 12535450
[TBL] [Abstract][Full Text] [Related]
5. Anabolic-androgenic steroids for alcoholic liver disease.
Rambaldi A; Gluud C
Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD003045. PubMed ID: 17054157
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of propylthiouracil for alcoholic liver disease--a Cochrane Hepato-Biliary Group Review.
Rambaldi A; Gluud C
Liver; 2001 Dec; 21(6):398-404. PubMed ID: 11903884
[TBL] [Abstract][Full Text] [Related]
7. S-adenosyl-L-methionine for alcoholic liver diseases.
Rambaldi A; Gluud C
Cochrane Database Syst Rev; 2006 Apr; (2):CD002235. PubMed ID: 16625556
[TBL] [Abstract][Full Text] [Related]
8. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.
Rambaldi A; Jacobs BP; Iaquinto G; Gluud C
Cochrane Database Syst Rev; 2005 Apr; (2):CD003620. PubMed ID: 15846671
[TBL] [Abstract][Full Text] [Related]
9. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis.
Rambaldi A; Gluud C
Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD002148. PubMed ID: 15846629
[TBL] [Abstract][Full Text] [Related]
10. S-adenosyl-L-methionine for alcoholic liver diseases.
Rambaldi A; Gluud C
Cochrane Database Syst Rev; 2001; (4):CD002235. PubMed ID: 11687153
[TBL] [Abstract][Full Text] [Related]
11. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis.
Rambaldi A; Gluud C
Cochrane Database Syst Rev; 2001; (3):CD002148. PubMed ID: 11687017
[TBL] [Abstract][Full Text] [Related]
12. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.
Rambaldi A; Jacobs BP; Gluud C
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003620. PubMed ID: 17943794
[TBL] [Abstract][Full Text] [Related]
13. Bezafibrate for primary biliary cirrhosis.
Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2012 Jan; 1():CD009145. PubMed ID: 22259000
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
[TBL] [Abstract][Full Text] [Related]
15. Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis.
Orlando R; Azzalini L; Orando S; Lirussi F
Cochrane Database Syst Rev; 2007 Jan; (1):CD005160. PubMed ID: 17253541
[TBL] [Abstract][Full Text] [Related]
16. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Gluud LL; Vilstrup H; Morgan MY
Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
[TBL] [Abstract][Full Text] [Related]
17. Bile acids for liver-transplanted patients.
Poropat G; Giljaca V; Stimac D; Gluud C
Cochrane Database Syst Rev; 2010 Mar; (3):CD005442. PubMed ID: 20238339
[TBL] [Abstract][Full Text] [Related]
18. Anabolic-androgenic steroids for alcoholic liver disease: a Cochrane review.
Rambaldi A; Iaquinto G; Gluud C
Am J Gastroenterol; 2002 Jul; 97(7):1674-81. PubMed ID: 12135017
[TBL] [Abstract][Full Text] [Related]
19. Branched-chain amino acids for people with hepatic encephalopathy.
Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis.
Lirussi F; Azzalini L; Orando S; Orlando R; Angelico F
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD004996. PubMed ID: 17253535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
